Cannabis-Based drug tested for calming severe aggression
NCT ID NCT05273320
Summary
This early study tested the safety of nabilone, a synthetic cannabis-like medication, in 20 adults with intellectual disabilities who experience severe, frequent aggressive behaviors. Researchers wanted to see if the drug was well-tolerated and to check for any early signs it might help reduce aggression. The goal was to gather safety information to plan a larger future study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTELLECTUAL DISABILITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M6J 1H4, Canada
Conditions
Explore the condition pages connected to this study.